Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02896582 |
|---|---|
| Brief Title: | Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance (LyMa101) |
| First Submitted : | September 6, 2016 |
| First Submitted that Met QC Criteria : | September 6, 2016 |
| First Posted : | September 12, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 13, 2024 |
| Last Update Posted : | March 15, 2024 |